- Home
- ISOU vs SRDX Comparison
ISOU vs SRDX Comparison
Compare ISOU & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISOU
- SRDX
- Stock Information
- Founded
- ISOU 2016
- SRDX 1979
- Country
- ISOU Canada
- SRDX United States
- Employees
- ISOU N/A
- SRDX N/A
- Industry
- ISOU
- SRDX Medical/Dental Instruments
- Sector
- ISOU
- SRDX Health Care
- Exchange
- ISOU Nasdaq
- SRDX Nasdaq
- Market Cap
- ISOU 391.8M
- SRDX 415.4M
- IPO Year
- ISOU N/A
- SRDX 1998
- Fundamental
- Price
- ISOU $8.24
- SRDX $32.38
- Analyst Decision
- ISOU
- SRDX Buy
- Analyst Count
- ISOU 0
- SRDX 3
- Target Price
- ISOU N/A
- SRDX $43.00
- AVG Volume (30 Days)
- ISOU 73.8K
- SRDX 318.4K
- Earning Date
- ISOU 08-01-2025
- SRDX 11-05-2025
- Dividend Yield
- ISOU N/A
- SRDX N/A
- EPS Growth
- ISOU N/A
- SRDX N/A
- EPS
- ISOU N/A
- SRDX N/A
- Revenue
- ISOU N/A
- SRDX $120,801,000.00
- Revenue This Year
- ISOU N/A
- SRDX N/A
- Revenue Next Year
- ISOU N/A
- SRDX $3.38
- P/E Ratio
- ISOU N/A
- SRDX N/A
- Revenue Growth
- ISOU N/A
- SRDX N/A
- 52 Week Low
- ISOU $5.72
- SRDX $26.00
- 52 Week High
- ISOU $8.72
- SRDX $40.39
- Technical
- Relative Strength Index (RSI)
- ISOU 61.35
- SRDX 35.24
- Support Level
- ISOU $7.79
- SRDX $34.00
- Resistance Level
- ISOU $8.72
- SRDX $34.74
- Average True Range (ATR)
- ISOU 0.43
- SRDX 1.41
- MACD
- ISOU 0.06
- SRDX -0.57
- Stochastic Oscillator
- ISOU 73.63
- SRDX 2.66
About ISOU IsoEnergy Ltd. Common Shares
IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.